Jennison Associates’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,504
Closed -$818K 573
2023
Q4
$818K Buy
22,504
+5,854
+35% +$201K ﹤0.01% 514
2023
Q3
$611K Buy
+16,650
New +$664K ﹤0.01% 520
2023
Q1
Sell
-18,492
Closed -$641K 584
2022
Q4
$641K Sell
18,492
-27,607
-60% -$965K ﹤0.01% 546
2022
Q3
$1.28M Buy
46,099
+12,466
+37% +$404K ﹤0.01% 483
2022
Q2
$997K Buy
+33,633
New +$1.13M ﹤0.01% 522

Other funds holding ADNT

Jennison Associates's ADNT Position: Q1 2024 in Review

Jennison Associates sold out of Adient (ADNT) in Q1 2024, closing a stake of 22,504 shares — an estimated $818K sold.

Jennison Associates first reported a position in ADNT in Q2 2022 and held it in 5 quarters. The position peaked at $1.28M in Q3 2022. 311 funds tracked by Wall St. Rank hold ADNT as of Q1 2024.

  • Jennison Associates reported no remaining Adient position as of Q1 2024 after selling out during the quarter.
  • Jennison Associates sold 22,504 Adient shares in Q1 2024, an estimated $818K.
  • Jennison Associates first reported a position in Adient in Q2 2022 and held it in 5 quarters.
  • Jennison Associates's Adient position peaked at $1.28M in Q3 2022.
  • 311 funds tracked by Wall St. Rank held Adient as of Q1 2024.

Based on Jennison Associates's 13F filing for Q1 2024, filed 2 May 2024.